The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

An oral vaccine reduced infection risk in a trial where people were deliberately exposed to high doses of norovirus, and ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The nation’s top health official, Robert F. Kennedy Jr., faces questions from lawmakers on his response to the measles ...

A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

A new study from the European Society of Cardiology found that receiving the shingles vaccine can lower the risk of heart ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

One in four dogs will get cancer at some point during their lifetime, and sometimes there aren’t a lot of options for ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...